Predicting Biotransformation Potential from Molecular Structure

The program PASS-BioTransfo is presented, which is capable of predicting many classes of biotransformation for chemical compounds. A particular class of biotransformation is defined by the chemical transformation type and may additionally include the name of the enzyme involved in a transformation. An evaluation of the approach is presented, using biotransformations taken from the databases Metabolite (MDL) and Metabolism (Accelrys), respectively. When trained with biotransformations from Metabolite, PASS-BioTransfo predicts 1927 classes of biotransformation; the average accuracy estimated in LOO cross-validation is about 88%. After training with the biotransformations from the Metabolism database, 178 classes of biotransformation are predicted with an average accuracy of about 85%. The results of cross-prediction with several training and evaluation sets are presented and discussed.

[1]  Lester A. Mitscher,et al.  Chapter 36 – Glossary of Terms Used in Medicinal Chemistry (IUPAC Recommendations 1997) , 1998 .

[2]  Anthony Long,et al.  Computer systems for the prediction of xenobiotic metabolism. , 2002, Advanced drug delivery reviews.

[3]  P N Judson,et al.  Knowledge-based expert systems for toxicity and metabolism prediction: DEREK, StAR and METEOR. , 1999, SAR and QSAR in environmental research.

[4]  F. Darvas,et al.  Predicting metabolic pathways by logic programming , 1988 .

[5]  D. Lewis,et al.  On the recognition of mammalian microsomal cytochrome P450 substrates and their characteristics: towards the prediction of human p450 substrate specificity and metabolism. , 2000, Biochemical pharmacology.

[6]  Vladimir Poroikov,et al.  Chemical Similarity Assessment through Multilevel Neighborhoods of Atoms: Definition and Comparison with the Other Descriptors , 1999, J. Chem. Inf. Comput. Sci..

[7]  Han van de Waterbeemd.  High-throughput and in silico techniques in drug metabolism and pharmacokinetics. , 2002, Current opinion in drug discovery & development.

[8]  Vladimir Poroikov,et al.  Robustness of Biological Activity Spectra Predicting by Computer Program PASS for Noncongeneric Sets of Chemical Compounds , 2000, J. Chem. Inf. Comput. Sci..

[9]  S. Anzali,et al.  Discriminating between drugs and nondrugs by prediction of activity spectra for substances (PASS). , 2001, Journal of medicinal chemistry.

[10]  Slobodan Petar Rendic.  Summary of information on human CYP enzymes: human P450 metabolism data , 2002, Drug metabolism reviews.

[11]  D. Lewis,et al.  COMPACT: a structural approach to the modelling of cytochromes P450 and their interactions with xenobiotics , 2001 .

[12]  Vladimir Poroikov,et al.  How to acquire new biological activities in old compounds by computer prediction , 2002, J. Comput. Aided Mol. Des..

[13]  L. Goodman,et al.  The Pharmacological Basis of Therapeutics , 1941 .

[14]  Gilles Klopman,et al.  META. 2. A Dictionary Model of Mammalian Xenobiotic Metabolism , 1994, J. Chem. Inf. Comput. Sci..

[15]  R. A. Y. Jones,et al.  Nomenclature for organic chemical transformations (Recommendations 1988) , 1989 .

[16]  V. Poroikov,et al.  Prediction of biological activity spectra for substances: evaluation on the diverse sets of drug-like structures. , 2003, Current medicinal chemistry.

[17]  Wolf-Dietrich Ihlenfeldt,et al.  PASS Biological Activity Spectrum Predictions in the Enhanced Open NCI Database Browser , 2003, J. Chem. Inf. Comput. Sci..

[18]  Han van de Waterbeemd,et al.  High-throughput and in silico techniques in drug metabolism and pharmacokinetics. , 2002 .

[19]  M. Leider.  Goodman & Gilman's The Pharmacological Basis of Therapeutics , 1985 .

[20]  A. R. Y. Jones,et al.  Nomenclature for Organic Chemical Transformations , 1990 .

[21]  Gilles Klopman,et al.  META. 1. A Program for the Evaluation of Metabolic Transformation of Chemicals , 1994, J. Chem. Inf. Comput. Sci..